what not to take with tirzepatide vs. Semaglutide: Which Weight Loss Medication Is Right for You? Who should NOT take Semaglutide,

They include, but are not limited to, an increase in water intake, a urinary tract infection (UTI), or the onset of a new disease such as diabetes, as the Mayo Clinic notes

Ozempic: Wegovy: Indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol

What to do Aim for 79 hours of high-quality sleep per night

used to baseline weight and labs Phase Treatment Duration 24 weeks Notes Once-daily tablet at the assigned dose, alongside calorie-restricted diet Phase Open-label extension (TIPO-4) Duration Up to 48 additional weeks Notes Continued 0.5 mg with optional up-titration to 1.0 mg in some patients Most published efficacy comes from the 24-week treatment window